NAOV
Income statement / Annual
Last year (2024), NanoVibronix, Inc.'s total revenue was $2.56 M,
an increase of 12.05% from the previous year.
In 2024, NanoVibronix, Inc.'s net income was -$3.71 M.
See NanoVibronix, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Operating Revenue |
$2.56 M |
$2.28 M |
$752,000.00 |
$1.70 M |
$623,000.00 |
$530,000.00 |
$318,000.00 |
$239,000.00 |
$229,000.00 |
$147,000.00 |
Cost of Revenue |
$1.05 M
|
$746,000.00
|
$585,000.00
|
$925,000.00
|
$409,000.00
|
$249,000.00
|
$158,000.00
|
$88,000.00
|
$88,000.00
|
$49,000.00
|
Gross Profit |
$1.51 M
|
$1.54 M
|
$167,000.00
|
$770,000.00
|
$214,000.00
|
$281,000.00
|
$160,000.00
|
$151,000.00
|
$141,000.00
|
$98,000.00
|
Gross Profit Ratio |
0.59
|
0.67
|
0.22
|
0.45
|
0.34
|
0.53
|
0.5
|
0.63
|
0.62
|
0.67
|
Research and Development Expenses |
$909,000.00
|
$185,000.00
|
$283,000.00
|
$293,000.00
|
$171,000.00
|
$514,000.00
|
$614,000.00
|
$693,000.00
|
$584,000.00
|
$399,000.00
|
General & Administrative Expenses |
$3.46 M
|
$3.92 M
|
$3.93 M
|
$5.06 M
|
$3.77 M
|
$3.82 M
|
$2.64 M
|
$2.08 M
|
$1.36 M
|
$747,000.00
|
Selling & Marketing Expenses |
$720,000.00
|
$864,000.00
|
$965,000.00
|
$1.10 M
|
$993,000.00
|
$1.10 M
|
$1.21 M
|
$465,000.00
|
$514,000.00
|
$377,000.00
|
Selling, General & Administrative Expenses |
$4.18 M
|
$4.79 M
|
$4.90 M
|
$6.16 M
|
$4.76 M
|
$4.92 M
|
$3.85 M
|
$2.55 M
|
$1.87 M
|
$1.12 M
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
-$1.63 M
|
$42,000.00
|
-$412,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Operating Expenses |
$5.09 M
|
$4.97 M
|
$5.18 M
|
$6.45 M
|
$4.93 M
|
$5.43 M
|
$4.46 M
|
$3.24 M
|
$2.46 M
|
$1.52 M
|
Cost And Expenses |
$6.14 M
|
$5.72 M
|
$5.76 M
|
$7.38 M
|
$5.34 M
|
$5.68 M
|
$4.62 M
|
$3.33 M
|
$2.55 M
|
$1.57 M
|
Interest Income |
$31,000.00
|
$0.00
|
$54,000.00
|
$48,000.00
|
$147,000.00
|
$15,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$135,000.00
|
$246,000.00
|
$347,000.00
|
$0.00
|
$147,000.00
|
$62,000.00
|
$22,000.00
|
$1.23 M
|
$0.00
|
$65,000.00
|
Depreciation & Amortization |
$1,000.00
|
$1,000.00
|
$1,000.00
|
$2,000.00
|
$2,000.00
|
$4,000.00
|
$6,000.00
|
$5,000.00
|
$7,000.00
|
$9,000.00
|
EBITDA |
-$3.55 M |
-$3.44 M |
-$5.01 M |
-$14.25 M |
-$4.16 M |
-$5.75 M |
-$4.28 M |
-$3.64 M |
-$2.69 M |
-$2.38 M |
EBITDA Ratio |
-1.39
|
-1.5
|
-6.66
|
-8.41
|
-6.68
|
-10.84
|
-13.44
|
-15.21
|
-11.76
|
-16.17
|
Operating Income Ratio |
-1.4
|
-1.51
|
-6.66
|
-3.35
|
-7.57
|
-9.72
|
-13.53
|
-12.93
|
-10.11
|
-9.69
|
Total Other Income/Expenses Net |
-$142,000.00
|
-$246,000.00
|
-$401,000.00
|
-$8.57 M
|
$408,000.00
|
-$660,000.00
|
$22,000.00
|
-$1.84 M
|
-$398,000.00
|
-$1.43 M
|
Income Before Tax |
-$3.72 M
|
-$3.68 M
|
-$5.41 M
|
-$14.25 M
|
-$4.31 M
|
-$5.81 M
|
-$4.28 M
|
-$4.93 M
|
-$2.71 M
|
-$2.86 M
|
Income Before Tax Ratio |
-1.46
|
-1.61
|
-7.2
|
-8.41
|
-6.92
|
-10.96
|
-13.46
|
-20.62
|
-11.85
|
-19.43
|
Income Tax Expense |
-$19,000.00
|
$29,000.00
|
$35,000.00
|
$32,000.00
|
$15,000.00
|
-$17,000.00
|
-$127,000.00
|
$38,000.00
|
$117,000.00
|
$28,000.00
|
Net Income |
-$3.71 M
|
-$3.71 M
|
-$5.45 M
|
-$14.28 M
|
-$4.33 M
|
-$5.79 M
|
-$4.15 M
|
-$4.97 M
|
-$2.83 M
|
-$2.88 M
|
Net Income Ratio |
-1.45
|
-1.63
|
-7.24
|
-8.43
|
-6.94
|
-10.93
|
-13.06
|
-20.77
|
-12.36
|
-19.62
|
EPS |
-1.37 |
-2.12 |
-3.84 |
-11.35 |
-8.4 |
-16.7 |
-12.88 |
-20 |
-12.37 |
-16.31 |
EPS Diluted |
-1.37 |
-2.12 |
-3.84 |
-11.35 |
-8.4 |
-16.7 |
-12.88 |
-20 |
-12.37 |
-16.31 |
Weighted Average Shares Out |
$2.70 M
|
$1.75 M
|
$1.42 M
|
$1.26 M
|
$514,905.00
|
$346,967.00
|
$322,417.00
|
$248,203.00
|
$228,923.00
|
$176,817.00
|
Weighted Average Shares Out Diluted |
$2.70 M
|
$1.75 M
|
$1.42 M
|
$1.26 M
|
$514,905.00
|
$346,967.00
|
$322,417.00
|
$248,203.00
|
$228,923.00
|
$176,817.00
|
Link |
|
|
|
|
|
|
|
|
|
|